Clinical Trial Update: A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive [Phase 3]

View source ↗

Summary

A Phase 3 study assessing the safety and efficacy of golimumab in methotrexate-naive rheumatoid arthritis patients; the trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Simponi (golimumab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2009-07-13